The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1050079410 10500794 10 F 20140930 20160923 20141007 20160930 EXP SE-AMGEN-SWESP2014076354 AMGEN 84.00 YR E F Y 71.00000 KG 20160930 CN SE SE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1050079410 10500794 1 PS PROLIA DENOSUMAB 1 Subcutaneous 60 MG, Q6MO 125320 60 MG SOLUTION FOR INJECTION
1050079410 10500794 2 C PANTOPRAZOL PANTOPRAZOLE SODIUM 1 Unknown 20 MG, QD 0 20 MG QD
1050079410 10500794 3 C AROMASIN EXEMESTANE 1 Unknown 25 MG, QD 0 25 MG QD
1050079410 10500794 4 C AMLODIPINE AMLODIPINE BESYLATE 1 Unknown 5 MG, QD 0 5 MG QD
1050079410 10500794 5 C LOSARTAN AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM 1 Unknown 100 MG/ 25 MG, QD 0 QD
1050079410 10500794 6 C KALCIPOS D3 2 Unknown 500 MG/400 IE, BID 0 BID
1050079410 10500794 7 C VITAMIN D CHOLECALCIFEROL 1 Unknown 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1050079410 10500794 1 Osteoporosis
1050079410 10500794 2 Prophylaxis
1050079410 10500794 3 Breast cancer
1050079410 10500794 4 Hypertonia
1050079410 10500794 5 Hypertonia

Outcome of event

Event ID CASEID OUTC COD
1050079410 10500794 OT
1050079410 10500794 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
1050079410 10500794 Abdominal pain upper
1050079410 10500794 Arthralgia
1050079410 10500794 Bacterial test
1050079410 10500794 Bursitis infective
1050079410 10500794 C-reactive protein abnormal
1050079410 10500794 Chest pain
1050079410 10500794 Drug dose omission
1050079410 10500794 Dry mouth
1050079410 10500794 Dyspnoea
1050079410 10500794 Erysipelas
1050079410 10500794 Erythema
1050079410 10500794 Fall
1050079410 10500794 Hypokalaemia
1050079410 10500794 Joint injury
1050079410 10500794 Malaise
1050079410 10500794 Musculoskeletal pain
1050079410 10500794 Nail injury
1050079410 10500794 Nausea
1050079410 10500794 Peripheral swelling
1050079410 10500794 Pyrexia
1050079410 10500794 Sepsis
1050079410 10500794 Skin warm
1050079410 10500794 Wound haemorrhage

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1050079410 10500794 1 20140520 0
1050079410 10500794 3 2003 0
1050079410 10500794 5 2012 0